|Day Low/High||82.74 / 84.03|
|52 Wk Low/High||64.18 / 86.72|
Hurricane Irma damage is less than expected, which lifts markets. In the portfolio, we add to one position while updating the ratings on two others.
- Three sub-analyses of the EMPA-REG OUTCOME® trial in adults with type 2 diabetes and established cardiovascular disease presented at the 53rd European Association for the Study of Diabetes Annual Meeting 2017
The U.S. Chamber of Commerce said Comcast, Eli Lily and cruise lines Norwegian and Royal Caribbean are among those donating.
A look at this weekend's news and the week ahead for these portfolio names.
Markets keep an eye on the storms while the Fed has a surprise. We add a name to the portfolio.
Hurricane Irma and disappointing Disney guidance caused market waves. Here's where stocks ended Thursday.
Stocks are mixed after Wednesday's gains. Here's where stocks are trading Thursday afternoon.
Stocks struggled for direction through the morning session as Hurricane Irma approached the U.S. mainland even as Texas and Louisiana continued recovery efforts after Hurricane Harvey.
Stocks fluctuate after Wednesday's gains. Here's where stocks are trading at the market open on Thursday.
The Boston firm unveils positive results from its Phase 3 study of duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Corporations have contributed at least $141.3 million to aid Hurricane Harvey relief efforts, as of Friday.
Jim Cramer has learned -- sometimes the hard way -- what works and what doesn't at Action Alerts PLUS. Here's how his thinking can help you profit.
After the news about resubmitting the NDA on baricitinib, the next big day is Sept. 10.
The San Diego firm said a Phase 3 study of Otividex in patients with Meniere's disease missed its primary endpoint.
Trump has both good news and bad news for the market, while Yellen has no news. In the portfolio, we add to 3 positions and upgrade another.
America's biggest hedge funds are worth over $6 trillion combined, and here are the most common stocks they're selling.
Markets see volatility as geopolitical tensions rise. We closed out one tech position and initiated another.
But, says Jim Cramer, almost every winning stock he's ever mentioned is overvalued or has been overvalued before its run.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.